PHS
CON

PFM Health Sciences’s Concentra Group Holdings CON Stock Holding History

PFM Health Sciences’s Portfolio CON Stock Details CON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-300,000
Closed -$6.71M – 102
2024
Q3 		$6.71M Buy
+300,000
New +$6.93M 0.38% 47

Other funds holding CON

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

PFM Health Sciences's CON Position: Q4 2024 in Review

PFM Health Sciences sold out of Concentra Group Holdings (CON) in Q4 2024, closing a stake of 300,000 shares — an estimated $6.71M sold.

PFM Health Sciences first reported a position in CON in Q3 2024 and held it in 1 quarter. The position peaked at $6.71M in Q3 2024. 236 funds tracked by Wall St. Rank hold CON as of Q4 2024.

  • PFM Health Sciences reported no remaining Concentra Group Holdings position as of Q4 2024 after selling out during the quarter.
  • PFM Health Sciences sold 300,000 Concentra Group Holdings shares in Q4 2024, an estimated $6.71M.
  • PFM Health Sciences first reported a position in Concentra Group Holdings in Q3 2024 and held it in 1 quarter.
  • PFM Health Sciences's Concentra Group Holdings position peaked at $6.71M in Q3 2024.
  • 236 funds tracked by Wall St. Rank held Concentra Group Holdings as of Q4 2024.

Based on PFM Health Sciences's 13F filing for Q4 2024, filed 14 Feb 2025.